BioRewind Skin Health Dietary Supplement

Turn back the clock on aging skin with BioRewind. This breakthrough skin health supplement targets glycation, the process responsible for the formation of harmful byproducts called Advanced Glycation End Products (AGEs). AGEs damage proteins such as collagen and elastin, leading to visible signs of skin aging. BioRewind's exclusive CORExtract™ Biotechnology, featuring Rosmarinic Acid and synergistic antioxidants, was shown to help reverse glycation and reduce AGE formation in clinical testing. Experience visibly healthier, younger-looking skin in as early as 8 weeks.

Why You’ll Love It: A clinically validated skin health dietary supplement that helps reverse glycation, a primary driver of skin aging, for younger and healthier looking skin.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Benefits

Experience the power of CORExtract ™ Biotechnology to reverse the aging effects of glycation at the source, resulting in healthier and younger looking skin.

How to Use

Take 2 capsules daily with meals. For a personalized regimen plan, discuss with your provider.

• For optimal results, we recommend the clinically tested regimen:
• Month 1 Quick Start: Take 2 capsules, 3 times daily with meals
• Month 2 Transition: Take 2 capsules, 2 times daily with meals
• Month 3+ Maintenance: Take 1 capsule, 2 times daily with meals

Ingredients

KEY INGREDIENTS

• CORExtract™
• Rosemary (Rosmarinus officinalis) leaf extract
• Biotin
• Zinc

FULL INGREDIENT LIST

• Rosemary (Rosmarinus officinalis) leaf extract, Biotin, Zinc
• Hydroxypropyl Methyl-cellulose, Maltodextrin, Glyceryl Dibehenate, Water, Silicon Dioxide

Before and After

After 8 weeks, patients experienced: 12% reduction in skin redness 23% reduction in skin dullness 26% reduction in rough skin texture After 12 weeks, patients experienced: 30% reduction in rough skin texture 28% reduction in skin dullness 14% reduction in skin redness *Results based 52 patients from a 12-week clinical trial.